Maternal Substance Abuse and the Developing Nervous System -

Maternal Substance Abuse and the Developing Nervous System (eBook)

eBook Download: PDF | EPUB
2012 | 1. Auflage
377 Seiten
Elsevier Science (Verlag)
978-0-08-092667-4 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
54,95 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
The purpose of this book is to review the basic science and clinical findings concerning maternal substance abuse and the developing nervous system of unborn children. The short-term but vitally significant repercussions of such exposure on biological development, with particular reference to the nervous system, are discussed. The book also discusses the profound influence of maternal substance abuse on behavior in adulthood, which is caused by subtle changes in the chemistry or structure of the developing nervous system. The subject will not only be of interest to clinical and basic science researchers and teachers in the field of maternal substance abuse, but also to individuals in psychology, social work, cellular and molecular biolgoy, embryology, neuroscience, pharmacology, and in clinical professions such as pediatrics, neonatology, and obstetrics. The breadth of topics covered includes alcohol, cocaine, opiates, nicotine, benzodiazepines, marijuana, and the role of stress and hormones. Emphasis is placed on the relationship of the effects of substance abuse on neurotrophic factors and receptors. - Shows how abused substances act directly or indirectly to mimic or influence the action of neurotrophic factors - Explains that the transient expression of peptides, neurotransmitters, and receptors can be markedly disturbed by drugs - Demonstrates that animal and tissue culture studies are consistent with clinical observations and important in understanding and ameliorating adverse actions of drugs in early life
The purpose of this book is to review the basic science and clinical findings concerning maternal substance abuse and the developing nervous system of unborn children. The short-term but vitally significant repercussions of such exposure on biological development, with particular reference to the nervous system, are discussed. The book also discusses the profound influence of maternal substance abuse on behavior in adulthood, which is caused by subtle changes in the chemistry or structure of the developing nervous system. The subject will not only be of interest to clinical and basic science researchers and teachers in the field of maternal substance abuse, but also to individuals in psychology, social work, cellular and molecular biolgoy, embryology, neuroscience, pharmacology, and in clinical professions such as pediatrics, neonatology, and obstetrics. The breadth of topics covered includes alcohol, cocaine, opiates, nicotine, benzodiazepines, marijuana, and the role of stress and hormones. Emphasis is placed on the relationship of the effects of substance abuse on neurotrophic factors and receptors. - Shows how abused substances act directly or indirectly to mimic or influence the action of neurotrophic factors- Explains that the transient expression of peptides, neurotransmitters, and receptors can be markedly disturbed by drugs- Demonstrates that animal and tissue culture studies are consistent with clinical observations and important in understanding and ameliorating adverse actions of drugs in early life

Front Cover 1
Maternal Substance Abuse and the Developing Nervous System 4
Copyright Page 5
Table of Contents 8
Dedication 6
Preface 16
Chapter 1. Introduction 18
REFERENCE 20
Chapter 2. Fetal Alcohol Syndrome and Fetal Alcohol Effects: A Clinical Perspective of Later Developmental Consequences 22
INTRODUCTION 22
FETAL ALCOHOL SYNDROME AND FETAL ALCOHOL EFFECTS: DIAGNOSTIC ISSUES AND TERMINOLOGY 23
CLINICAL STUDIES OF FETAL ALCOHOL SYNDROME, FETAL ALCOHOL EFFECTS, AND CHILDREN OF ALCOHOLIC MOTHERS 25
EPIDEMIOLOGIC OR CASE CONTROL STUDIES 32
CONCLUSIONS 36
RECOMMENDATIONS 37
ACKNOWLEDGMENTS 39
REFERENCES 39
Chapter 3. Effects of Prenatal Alcohol Exposure 44
INTRODUCTION 44
DEFINITION OF FETAL ALCOHOL SYNDROME 44
METHODOLOGICAL ISSUES IN THE ASSESSMENT OF THE EFFECTS OF PRENATAL SUBSTANCE USE 45
EPIDEMIOLOGY 47
STUDIES OF PATIENTS WITH FETAL ALCOHOL SYNDROME 49
STUDIES OF OFFSPRING OF ALCOHOLIC WOMEN 50
EFFECTS OF DRINKING DURING PREGNANCY ON OFFSPRING AT BIRTH 50
LONG-TERM EFFECTS OF PRENATAL ALCOHOL EXPOSURE 52
SUMMARY AND CONCLUSIONS 56
REFERENCES 57
Chapter 4.Fetal Alcohol Effects: Rat Model of Alcohol Exposure during the Brain Growth Spurt 62
TERATOGENIC EFFECTS OF ALCOHOL IN HUMANS 62
CURRENT ROLE OF ANIMAL MODELS IN STUDIES OF FETAL ALCOHOL EFFECTS 63
AN ANIMAL MODEL OF BINGE DRINKING DURING THE THIRD TRIMESTER 66
ALTERATIONS IN BRAIN MORPHOLOGY 67
DEPENDENCE OF EFFECTS ON BLOOD ALCOHOL CONCENTRATION 75
CENTRAL NERVOUS SYSTEM EFFECTS INDUCED BY LOW BLOOD ALCOHOL CONCENTRATIONS 81
TEMPORAL WINDOWS OF VULNERABILITY 82
SUMMARY 86
ACKNOWLEDGMENTS 87
REFERENCES 87
Chapter 5. Clinical Implications of Smoking: Determining Long-Term Teratogenicity 94
INTRODUCTION 94
THE OTTAWA PRENATAL PROSPECTIVE STUDY 95
PREVALENCE AND PATTERNS OF SMOKING 97
COURSE OF PREGNANCY AND BIRTH WEIGHT 98
NEONATAL BEHAVIORAL CORRELATES OF PRENATAL EXPOSURE TO CIGARETTES 99
INFANT BEHAVIORAL CORRELATES OF PRENATAL EXPOSURE TO CIGARETTES 101
CHILDHOOD BEHAVIORAL CORRELATES OF PRENATAL EXPOSURE TO CIGARETTES 103
INVOLUNTARY SMOKING DURING PREGNANCY 105
SUMMARY AND CONCLUSIONS 108
ACKNOWLEDGMENTS 110
REFERENCES 110
Chapter 6. Prenatal Exposure to Nicotine: What Can We Learn from Animal Models? 114
INTRODUCTION 114
THE NICOTINE-NJECTION MODEL 117
THE NICOTINE-INFUSION MODEL 123
THE ROLE OF NICOTINIC CHOLINERGIC RECEPTORS 129
CONCLUSIONS 133
ACKNOWLEDGMENT 136
REFERENCES 136
Chapter 7. Prenatal Cocaine and Marijuana Exposure: Research and Clinical Implications 142
INTRODUCTION 142
METHODOLOGIC ISSUES 143
A MULTIFACTORIAL DEVELOPMENT MODEL 150
COCAINE 153
MARIJUANA 160
CLINICAL IMPLICATIONS 163
ACKNOWLEDGMENTS 164
REFERENCES 164
Chapter 8. Cocaine and the Developing Nervous System: Laboratory Findings 172
INTRODUCTION 172
ANIMAL MODEL USED 173
MATERNAL/LITTER DATA 176
COGNITIVE EFFECTS IN OFFSPRING 177
NEURAL ALTERATIONS IN OFFSPRING 182
ALTERATIONS IN THE LATER REWARDING EFFICACY OF COCAINE: INCREASED DRUG ABUSE LIABILITY IN COCAINE-EXPOSED OFFSPRING? 186
SUMMARY AND CONCLUSIONS 188
ACKNOWLEDGMENTS 189
REFERENCES 189
Chapter 9. Maternal Opioid Drug Use and Child Development 194
NATURE OF OPIOID DRUG USE 194
IMPORTANCE OF RESEARCH ON HUMANS 195
PHYSICAL GROWTH 196
SUDDEN INFANT DEATH SYNDROME 200
NEONATAL BEHAVIOR 201
INFANCY AFTER THE NEONATAL PERIOD 207
DEVELOPMENT IN EARLY CHILDHOOD 212
DEVELOPMENT DURING MIDDLE CHILDHOOD AND ADOLESCENCE 215
STAGES IN HUMAN RESEARCH ON PRENATAL SUBSTANCE EXPOSURE 216
EVIDENCE FOR TERATOGENIC OR TOXICOLOGICAL EFFECTS 217
EVIDENCE FOR OTHER BIOLOGICAL EFFECTS 219
EVIDENCE FOR ENVIRONMENTAL EFFECTS 220
ACKNOWLEDGMENT 224
REFERENCES 224
Chapter 10. Effects of Opiates on the Physiology of the Fetal Nervous System 232
INTRODUCTION 232
ANIMAL MODEL 233
EFFECTS OF EXOGENOUSLY ADMINISTERED OPIATES ON THE FETAL NERVOUS SYSTEM 233
INTRAUTERINE WITHDRAWAL 250
ROLE OF ENDOGENOUS OPIATE PEPTIDES IN CONTROL OF FETAL BREATHING 251
CLINICAL IMPLICATIONS 252
REFERENCES 253
Chapter 11. Maternal Exposure to Opioids and the Developing Nervous System: Laboratory Findings 258
INTRODUCTION 258
CLINICAL OBSERVATIONS 259
LABORATORY FINDINGS: OPIOID EXPOSURE AND NEURAL DEVELOPMENT 264
ETIOLOGICAL AND MECHANISTIC CONSIDERATIONS OF THE PERINATAL OPIOID SYNDROME 285
REFERENCES 289
Chapter 12. Benzodiazepines and the Developing Nervous System: Laboratory Findings and Clinical Implications 300
INTRODUCTION 300
MECHANISMS OF ACTION OF BENZODIAZEPINE COMPOUNDS 302
BEHAVIORAL CONSEQUENCES OF PRENATAL EXPOSURE TO BENZODIAZEPINES 304
NEURAL AND HORMONAL CONSEQUENCES OF PRENATAL EXPOSURE TO BENZODIAZEPINES 315
CLINICAL IMPLICATIONS 328
CONCLUSIONS 331
ACKNOWLEDGMENTS 332
REFERENCES 332
Chapter 13. Drug Effects on Sexual Differentiation of the Brain: Role of Stress and Hormones in Drug Actions 340
INTRODUCTION 340
BASIC FEATURES OF SEXUAL DIFFERENTIATION 341
GENERAL CONSIDERATIONS IN THE ACTIONS OF DRUGS ON THE DEVELOPING BRAIN 351
EFFECTS OF STRESS AND DRUGS ON BRAIN SEXUAL DIFFERENTIATION 354
DISCUSSION 370
ACKNOWLEDGMENTS 373
REFERENCES 373
INDEX 386

2

Fetal Alcohol Syndrome and Fetal Alcohol Effects: A Clinical Perspective of Later Developmental Consequences


Ann Pytkowicz Streissguth    Fetal Alcohol and Drug Uni, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington

INTRODUCTION


Alcohol is now well recognized as a teratogenic drug: prenatal exposure can cause death to the embryo and fetus, growth deficiency, malformations, and central nervous system aberrations that can last a lifetime. Whereas definitive documentation of the etiology and mechanisms comes from the experimental animal literature (see Goodlett and West, Chapter 4), the clinical literature is important in understanding the significant impact of this most widely used teratogen on our children. The epidemiologic literature is relevant for establishing public policy and guiding programs of prevention for this most preventable cause of mental retardation and developmental disability, and understanding the clinical phenomena of fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE) is essential for developing appropriate treatment and intervention programs for affected children so that they can lead as productive and fulfilling lives as possible. There has been a shocking paucity of such research in the United States in the past 18 years since FAS was identified.

Fetal alcohol syndrome is generally recognized as the leading known cause of mental retardation (Abel and Sokol, 1987), surpassing Down’s syndrome and spina bifida. (Most mental retardation cannot be attributed to a specific etiology.) Precise figures on FAS are difficult to obtain, however, and it seems likely that most attempts at estimating prevalence [including those most recently proposed by Abel and Sokol (1991)] are underestimates owing to difficulties with ascertainment and identification, confusion over diagnostic criteria, and problems in making interpretations based on literature surveys, including studies of variable validity. FAS is a clinical diagnosis (see below). The term FAS does not include all individuals affected by alcohol in utero, but rather it represents one specific and identifiable end of the continuum of disabilities caused by maternal alcohol use during pregnancy.

The clinical features of FAS were independently identified in France (Lemoine et al., 1968) and the United States (Jones et al., 1973; Jones and Smith, 1973). Most of the patients described have been infants or young children, but increasingly maladaptive behaviors among adolescents with FAS (Streissguth et al., 1991) make this an important topic for further study. A systematic examination of all school-age children with only mild mental retardation (IQ 55 to 70), born in Sweden during a 2-year period, indicated that 8% were afflicted with alcohol-related disabilities (Hagberg et al., 1981a,b). A recent report involving ophthalmology examinations of this same cohort raised the proportion with suspected FAS to 10% [a larger proportion than was identified by all known genetic disorders (Hagberg et al., 1981a,b; Stromland, 1990)]. Enough is currently known to indicate that FAS is a major health problem. The fact that precise figures are not available should not dissuade us from recognizing the urgency of the need for research on the characteristics and special needs of this underserved population of disabled persons.

FETAL ALCOHOL SYNDROME AND FETAL ALCOHOL EFFECTS: DIAGNOSTIC ISSUES AND TERMINOLOGY


Fetal alcohol syndrome is diagnosed when patients have a positive history of maternal alcohol abuse during pregnancy and (1) growth deficiency of prenatal origin (height and/or weight); (2) a pattern of specific minor anomalies that includes a characteristic facies (generally defined by short palpebral fissures, midface hypoplasia, smooth and/or long philtrum, and thin upper lip); and (3) central nervous system manifestations (including microcephaly or history of delayed development, hyperactivity, attention deficits, learning disabilities, intellectual deficits, or seizures) (Clarren and Smith, 1978; Smith, 1982). Patients exposed to alcohol in utero with some partial FAS phenotype, and/or central nervous system dysfunction, but without sufficient features for a firm diagnosis of FAS or strong consideration of any alternative diagnosis, are identified as possible FAE (Clarren and Smith, 1978).

Fetal alcohol syndrome is a specific medical diagnosis usually given by a dysmorphologist, a geneticist, or a pediatrician with special training in birth defects or dysmorphology. It is not appropriately diagnosed by checklists or without a full clinical examination by a specially trained person. Unfortunately, most physicians have not received special training in syndrome identification, and as dysmorphology is a rather new field, many persons with FAS go unrecognized. This is a particular problem with regard to persons who have not been identified before puberty, as the facial features are less distinctive in adolescence and adulthood. The optimal age for making the diagnosis is between 8 months and 8 years, although the most severely affected children can be identified at birth by a skilled diagnostician. Diagnosis in the adolescent and adult is facilitated by photographs from infancy and childhood.

Fetal alcohol effects is a term used in two different ways. In the clinical sense, possible or probable FAE refers to individual children given a clinical examination who were known to be born to an alcohol-abusing mother and who have some, but not all, of the characteristics necessary for a diagnosis of the full FAS. Partial syndrome expression is not uncommon in syndromology. The words possible or probable precede the term FAE as an expression of uncertainty that the observed characteristics (in the absence of the full syndrome) are all attributable to alcohol. From the standpoint of understanding the patient’s needs, the distinction may be irrelevant. Clearly for research purposes and for making prognostications for the individual patient, the criteria used for making the diagnosis are extremely important.

Fetal alcohol effects is also a generic term used for all the “effects” or outcomes known from epidemiologic studies to be caused by alcohol (low birth weight is an example). Whereas it is clear from group studies that low birth weight is an effect associated with maternal alcohol abuse during pregnancy, it is not possible to say with any degree of certainty that low birth weight in an individual child is indeed caused by alcohol. There are, of course, many causes of low birth weight, of which prenatal alcohol exposure is only one.

Considerable confusion exists in the medical literature regarding the use of the terms FAS and FAE. It is unclear what the relationship of these clinical findings is to studies that attempt to designate children as FAS or FAE based on checklist criteria, in the absence of a full clinical examination by a qualified diagnostician. In our own experience, anomalies tallies by highly trained technicians have not correlated well with the clinical diagnosis of FAS as determined by an experienced diagnostician (unpublished data from the Seattle Longitudinal Study on Alcohol and Pregnancy (1974–1987); see also Clarren et al., 1987). We would not necessarily expect the findings from long-term studies of clinically diagnosed patients to be congruent with the findings from studies attempting to identify newborns based on anomalies tallies, particularly in view of the well-documented differences in minor anomalies among different racial groups, which are seldom discussed in the studies identifying patients with anomalies tallies.

In our opinion, the European clinicians diagnosing FAS identify children quite similar to those identified by dysmorphologists in the United States (e.g., Lemoine et al., 1968, and Dehaene et al., 1977a,b, in France; Majewski and Majewski, 1988, Spohr and Steinhausen, 1987, and Löser and Ilse, 1991, in Germany; Olegard and colleagues, 1984, in Sweden; and Gairi, 1990, in Spain). However, direct extrapolation to U.S. statistics is difficult because European clinicians often use a classification system, involving light, moderate, and severe categories of FAS which do not translate easily to the nomenclature used in the United States.

For the purposes of this chapter, the terms FAS and FAE will refer to children whose diagnoses have been established by clinical examination by persons qualified to make this diagnosis. Most of these patients were referred for clinical examinations, unless otherwise specified. This chapter will focus on later development, meaning school-age children, adolescents, and adults. Studies on the early developmental effects of alcohol (infancy or preschool ages) have been reviewed earlier (Streissguth, 1986). This chapter will also not review the literature on the broader realm of non-behavioral fetal alcohol effects deriving from epidemiologic studies, as these have been recently reviewed elsewhere (Little and Wendt, 1991; Streissguth et al., in press).

CLINICAL STUDIES OF FETAL ALCOHOL SYNDROME, FETAL ALCOHOL EFFECTS, AND CHILDREN OF ALCOHOLIC MOTHERS


Hundreds of clinical reports on individual children with FAS have appeared in the medical literature. However, only a few clinicians, mostly from Europe, have reported clinical findings on groups of school-age children with FAS/FAE or...

PDFPDF (Adobe DRM)
Größe: 52,8 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 9,1 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich